SCHEDULE 13G 0002099921 XXXXXXXX LIVE Ordinary Shares, par value of US$0.0001 per share 09/30/2025 0002011674 YD Bio Ltd G98301107 12F., No. 3, Xingnan St Nangang Dist., Taipei City F5 115001 Rule 13d-1(d) Ethan Shen F5 54345011.00 0.00 54345011.00 0.00 54345011.00 N 77.1 IN Number in each of Rows 5, 7 and 9 consists of (i) 43,120,858 Ordinary shares held by YD Biopharma Holding Limited and (ii) 11,224,153 Ordinary shares held by EG Biomed Limited. YD Biopharma Holding Limited is a company incorporated in the Cayman Islands and Dr. Shen is the beneficial owner of all of the equity interests issued by YD Biopharma Holding Limited. EG Biomed Limited is a company incorporated in the Cayman Islands and wholly owned by Dr. Shen. Number in Row 11 is based on a total of 70,521,359 ordinary shares of the Issuer of November 17, 2025 reported in the Issuer's Rule 424(b)(3) Prospectus filed on November 17, 2025. YD Biopharma Holding Limited E9 43120858.00 0.00 43120858.00 0.00 43120858.00 N 61.1 CO Number in each of Rows 5, 7 and 9 consists of 43,120,858 Ordinary shares held by YD Biopharma Holding Limited. YD Biopharma Holding Limited is a company incorporated in the Cayman Islands and Dr. Shen is the beneficial owner of all of the equity interests issued by YD Biopharma Holding Limited. Number in Row 11 is based on a total of 70,521,359 ordinary shares of the Issuer of November 17, 2025 reported in the Issuer's Rule 424(b)(3) Prospectus filed on November 17, 2025. EG Biomed Limited E9 11224153.00 0.00 11224153.00 0.00 11224153.00 N 15.9 CO Number in each of Rows 5, 7 and 9 consists of 11,224,153 Ordinary shares held by EG Biomed Limited. EG Biomed Limited is a company incorporated in the Cayman Islands and wholly owned by Dr. Shen. Number in Row 11 is based on a total of 70,521,359 ordinary shares of the Issuer of November 17, 2025 reported in the Issuer's Rule 424(b)(3) Prospectus filed on November 17, 2025. YD Bio Ltd 12F., No. 3, Xingnan St., Nangang Dist., Taipei City 115001, Taiwan Ethan Shen YD Biopharma Holding Limited EG Biomed Limited Ethan Shen: 15 F.-5 No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist. Taipei City 115011, Taiwan YD Biopharma Holding Limited: c/o YD Biopharma Limited, 12F., No. 3, Xingnan St., Nangang Dist., Taipei City 115001, Taiwan EG Biomed Limited: 15 F.-5, No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist., Taipei City 115011, Taiwan Ethan Shen - Taiwan YD Biopharma Holding Limited - Cayman Islands EG Biomed Limited - Cayman Islands Y See Row (9) of each cover page. Ethan Shen: 54,345,011 YD Biopharma Holding Limited: 43,120,858 EG Biomed Limited: 11,224,153 See Row (11) of each cover page. Ethan Shen: 77.1% YD Biopharma Holding Limited: 61.1% EG Biomed Limited: 15.9% See Row (5) of each cover page. Ethan Shen: 54,345,011 YD Biopharma Holding Limited: 43,120,858 EG Biomed Limited: 11,224,153 See Row (6) of each cover page. Ethan Shen: 0 YD Biopharma Holding Limited: 0 EG Biomed Limited: 0 See Row (7) of each cover page. Ethan Shen: 54,345,011 YD Biopharma Holding Limited: 43,120,858 EG Biomed Limited: 11,224,153 See Row (8) of each cover page. Ethan Shen: 0 YD Biopharma Holding Limited: 0 EG Biomed Limited: 0 Y Y Y Y Y Y 99.1 Joint Filing Agreement Ethan Shen /s/ Ethan Shen 12/16/2025 YD Biopharma Holding Limited /s/ Ethan Shen 12/16/2025 EG Biomed Limited /s/ Ethan Shen 12/16/2025